法国肺高血压登记研究对细化四层风险评分的外部验证
该研究基于法国肺动脉高压(PAH)登记队列,在基线及首次再评估时应用COMPERA提出的四层风险分层法(低、中低、中高、高),并对WHO功能分级、6分钟步行距离和NT-proBNP采用细化界值。结果显示四层法识别出四个 distinct 风险组,预测死亡略优于三层法,随访期区分度显著更高,且53%患者风险类别较基线改变(三层法为39%)。
要点
- 四层风险分层在随访期对生存的预测区分度显著高于三层法。
- 四层法使53%患者风险类别较基线改变,高于三层法的39%。
- 达到或维持低风险状态的患者生存最佳,中低与中高组间差异更细致。
核心结论
- 四层风险分层法细化风险预测,尤其在中风险类别内,预测生存更优且对变化更敏感。
研究设计与样本
- 基于法国PAH登记的前瞻性队列,纳入基线n=2879例新发患者,在基线和首次再评估时应用四层风险法。
主要发现
- 基线时四层法识别出四个 distinct 风险组,预测死亡略优于三层法。
- 随访期四层模型区分度显著高于三层法,并在特发性PAH、结缔组织病相关PAH、先天性心脏病和门肺高压亚组中细化风险分类。
- 四层法下53%患者风险类别较基线改变,三层法为39%。
- 达到或维持低风险状态者生存最佳,中低与中高风险组间生存差异更细致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Contemporary risk assessment tools categorise patients with pulmonary arterial hypertension (PAH) as low, intermediate or high risk. A minority of patients achieve low risk status with most remaining intermediate risk. Our aim was to validate a four-stratum risk assessment approach categorising patients as low, intermediate-low, intermediate-high or high risk, as proposed by the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA) investigators. METHODS: We evaluated incident patients from the French PAH Registry and applied a four-stratum risk method at baseline and at first reassessment. We applied refined cut-points for three variables: World Health Organization functional class, 6-min walk distance and N-terminal pro-brain natriuretic peptide. We used Kaplan-Meier survival analyses and Cox proportional hazards regression to assess survival according to three-stratum and four-stratum risk approaches. RESULTS: At baseline (n=2879), the four-stratum approach identified four distinct risk groups and performed slightly better than a three-stratum method for predicting mortality. Four-stratum model discrimination was significantly higher than the three-stratum method when applied during follow-up and refined risk categories among subgroups with idiopathic PAH, connective tissue disease-associated PAH, congenital heart disease and portopulmonary hypertension. Using the four-stratum approach, 53% of patients changed risk category from baseline compared to 39% of patients when applying the three-stratum approach. Those who achieved or maintained a low risk status had the best survival, whereas there were more nuanced differences in survival for patients who were intermediate-low and intermediate-high risk. CONCLUSIONS: The four-stratum risk assessment method refined risk prediction, especially within the intermediate risk category of patients, performed better at predicting survival and was more sensitive to change than the three-stratum approach.
引用
- Boucly A, Weatherald J, Savale L, et al. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry. Eur Respir J. 2022. PMID: 34737227. doi:10.1183/13993003.02419-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。